356 related articles for article (PubMed ID: 23933785)
1. Clinical value of serum CA19-9 as a prognostic factor for the ampulla of Vater carcinoma.
Kurihara C; Yoshimi F; Sasaki K; Iijima T; Kawasaki H; Nagai H
Hepatogastroenterology; 2013 Oct; 60(127):1588-91. PubMed ID: 23933785
[TBL] [Abstract][Full Text] [Related]
2. Factors predicting survival and pathological subtype in patients with ampullary adenocarcinoma.
Okano K; Oshima M; Yachida S; Kushida Y; Kato K; Kamada H; Wato M; Nishihira T; Fukuda Y; Maeba T; Inoue H; Masaki T; Suzuki Y
J Surg Oncol; 2014 Aug; 110(2):156-62. PubMed ID: 24619853
[TBL] [Abstract][Full Text] [Related]
3. Glasgow prognostic score predicts therapeutic outcome after pancreaticoduodenectomy for carcinoma of the ampulla of vater.
Shiba H; Misawa T; Fujiwara Y; Futagawa Y; Furukawa K; Haruki K; Iwase R; Wakiyama S; Ishida Y; Yanaga K
Anticancer Res; 2013 Jun; 33(6):2715-21. PubMed ID: 23749931
[TBL] [Abstract][Full Text] [Related]
4. Improved survival for adenocarcinoma of the ampulla of Vater: fifty-five consecutive resections.
Duffy JP; Hines OJ; Liu JH; Ko CY; Cortina G; Isacoff WH; Nguyen H; Leonardi M; Tompkins RK; Reber HA
Arch Surg; 2003 Sep; 138(9):941-8; discussion 948-50. PubMed ID: 12963649
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological and operative factors for prognosis of carcinoma of the ampulla of vater.
Inoue Y; Hayashi M; Hirokawa F; Egashira Y; Tanigawa N
Hepatogastroenterology; 2012; 59(117):1573-6. PubMed ID: 22683975
[TBL] [Abstract][Full Text] [Related]
6. [Determinants of long-term survival after pancreaticoduodenectomy for ampulla of Vater carcinoma].
Chen JY; Cai SW; Zhang WZ; Huang XQ; Liu R; Wang J; Chen YL; Ji WB; Shi XJ; Chen MY; Liu ZW; Zhao XQ; Feng YQ; Huang ZQ; Dong JH
Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(48):3409-12. PubMed ID: 20223115
[TBL] [Abstract][Full Text] [Related]
7. Factors influencing recurrence after curative resection for ampulla of Vater carcinoma.
Park JS; Yoon DS; Kim KS; Choi JS; Lee WJ; Chi HS; Kim BR
J Surg Oncol; 2007 Mar; 95(4):286-90. PubMed ID: 17326125
[TBL] [Abstract][Full Text] [Related]
8. Carcinoma of the ampulla of Vater: results of surgical treatment of a single center.
Memon MA; Shiwani MH; Anwer S
Hepatogastroenterology; 2004; 51(59):1275-7. PubMed ID: 15362731
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of pathologic subtype in curatively resected ampulla of vater cancer.
Kim WS; Choi DW; Choi SH; Heo JS; You DD; Lee HG
J Surg Oncol; 2012 Mar; 105(3):266-72. PubMed ID: 21882202
[TBL] [Abstract][Full Text] [Related]
10. Cyclin D1 and bax influence the prognosis after pancreatoduodenectomy for periampullary adenocarcinoma.
Tomazic A; Pegan V; Ferlan-Marolt K; Pleskovic A; Luzar B
Hepatogastroenterology; 2004; 51(60):1832-7. PubMed ID: 15532837
[TBL] [Abstract][Full Text] [Related]
11. Ampullary cancer and preoperative jaundice: possible indication of the minimal surgery.
Uchida H; Shibata K; Iwaki K; Kai S; Ohta M; Kitano S
Hepatogastroenterology; 2009; 56(93):1194-8. PubMed ID: 19760968
[TBL] [Abstract][Full Text] [Related]
12. A survival predictive model in patients undergoing radical resection of ampullary adenocarcinoma.
Wang CH; Mo LR; Lin RC; Kuo JJ; Chang KK; Lin YW; Yang DM; Yau MP; Cho CY
Hepatogastroenterology; 2004; 51(59):1495-9. PubMed ID: 15362785
[TBL] [Abstract][Full Text] [Related]
13. Pathological factors influencing survival of carcinoma of the ampulla of Vater.
Mori K; Ikei S; Yamane T; Yamaguchi Y; Katsumori T; Shibata Y; Arai T
Eur J Surg Oncol; 1990 Jun; 16(3):183-8. PubMed ID: 2347413
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in patients with carcinoma of the papilla of Vater.
Tanaka S; Hirohashi K; Tanaka H; Yamamoto T; Kubo S; Shuto T; Takemura S; Kinoshita H
Hepatogastroenterology; 2002; 49(46):1116-9. PubMed ID: 12143216
[TBL] [Abstract][Full Text] [Related]
15. Preoperative platelet count predicts survival after resection of periampullary adenocarcinoma.
Schwarz RE; Keny H
Hepatogastroenterology; 2001; 48(41):1493-8. PubMed ID: 11677994
[TBL] [Abstract][Full Text] [Related]
16. [Predictors of recurrence after pancreaticoduodenectomy for carcinoma of the ampulla of Vater].
Chen J; Cai S; Dong J
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Sep; 32(9):1242-4. PubMed ID: 22985555
[TBL] [Abstract][Full Text] [Related]
17. Transduodenal local resection for low-risk group ampulla of vater carcinoma.
Park JS; Yoon DS; Park YN; Lee WJ; Chi HS; Kim BR
J Laparoendosc Adv Surg Tech A; 2007 Dec; 17(6):737-42. PubMed ID: 18158802
[TBL] [Abstract][Full Text] [Related]
18. Carcinoma of the ampulla of Vater: morphological and immunophenotypical classification predicts overall survival.
Morini S; Perrone G; Borzomati D; Vincenzi B; Rabitti C; Righi D; Castri F; Manazza AD; Santini D; Tonini G; Coppola R; Onetti Muda A
Pancreas; 2013 Jan; 42(1):60-6. PubMed ID: 22889982
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of solitary lymph node metastasis in carcinoma of the ampulla of Vater].
Shan Y; Zhao DB; Che X; Wang JX; Shao YF; Zhao P
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):694-6. PubMed ID: 17274378
[TBL] [Abstract][Full Text] [Related]
20. Pancreaticoduodenectomy for periampullary adenocarcinoma.
Andersen HB; Baden H; Brahe NE; Burcharth F
J Am Coll Surg; 1994 Nov; 179(5):545-52. PubMed ID: 7952456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]